Our Board of Directors
Our board is comprised of years of leadership and professional experience; each is committed to our mission to raise awareness and funds in the fight against pediatric cancer.
NCI News Releases
24 January 2021
The latest cancer news from the U.S. government's principal agency for cancer research.-
Some postmenopausal women with breast cancer may forgo chemotherapy
Some postmenopausal women with HR-positive, HER2-negative breast cancer may not benefit from chemotherapy and can safely forgo the treatment, according to clinical trial results presented at the San Antonio Breast Cancer Symposium.
-
Study of “exceptional responders” yields clues to cancer and potential treatments
A comprehensive analysis of patients with cancer who had exceptional responses to therapy has revealed molecular changes in the patients’ tumors that may explain some of the exceptional responses.
-
NCI, NIBIB award contracts to develop innovative digital health technologies for COVID-19
NCI and the National Institute of Biomedical Imaging and Bioengineering have awarded seven contracts to develop digital health solutions, like smartphone apps, wearable devices, and software, that help address the COVID-19 pandemic.
NCI Fact Sheets
24 January 2021
The latest NCI fact sheets on a wide array of cancer topics including risk factors, prevention, support, treatment, and more.-
Tumor Markers
A fact sheet that defines tumor markers and describes how they can be used to aid diagnosis and treatment.
-
Targeted Cancer Therapies
A fact sheet that describes targeted cancer therapies, which are drugs that interfere with specific molecules involved in cancer cell growth and survival.
-
Genetic Testing for Inherited Cancer Susceptibility Syndromes
A fact sheet about genetic testing for inherited cancer risk, including who should consider testing, how to understand test results, and who has access to a person’s test results. Also contains information about at-home, or direct-to-consumer, genetic tests.
